NEW YORK--(BUSINESS WIRE)--Sep. 20, 2022--Columbia Care Inc.(NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) announced today that, at the annual general meeting (the “Meeting”) of shareholders of the Company (“Shareholders”) that was held onTuesday, September 20, 2022, all nine nominees for the board of directors of the Company were elected, the voting results of which are as follows:
Director | Number and percentage of common
shares(1) of the Corporation (“Shares”)
represented in person or by proxy and
entitled to vote at the Meeting that
were voted FOR | Number and percentage of Shares represented
in person or by proxy and entitled to vote at
the Meeting that were WITHHELD from voting |
Nicholas Vita | 115,340,138 (96.14%) | 4,632,880 (3.86%) |
Michael Abbott | 112,854,970 (94.07%) | 7,118,048 (5.93%) |
Frank Savage | 114,522,688 (95.46%) | 5,450,330 (4.54%) |
James A.C. Kennedy | 118,891,321 (99.10%) | 1,081,697 (0.90%) |
Jonathan P. May | 119,079,350 (99.26%) | 893,668 (0.74%) |
Jeff Clarke | 119,069,317 (99.25%) | 903,701 (0.75%) |
Alison Worthington | 119,308,625 (99.45%) | 664,393 (0.55%) |
Julie Hill | 119,335,770 (99.47%) | 637,248 (0.53%) |
Philip Goldberg | 116,870,341 (97.41%) | 3,102,677 (2.59%) |
Notes:
(1) Assuming conversion of all proportionate voting shares into common shares. |
Shareholders also approved the re-appointment ofDavidson & Company LLPas auditor of the Company for the ensuing year and the authorization of directors to fix their remuneration.
Full details of the foregoing are contained in the Report of Voting Results for the Meeting which has been filed on SEDAR at www.sedar.com.
AboutColumbia Care Inc.
Columbia Careis one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions.Columbia Careoperates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development.Columbia Careis one of the original multi-state providers of medical cannabis in theU.S.and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information onColumbia Care, please visit www.columbia.care.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220920006208/en/
Investor Contact
Lee Ann Evans
Capital Markets
ir@col-care.com
Media Contact
Lindsay Wilson
Communications
+1.978.662.2038
media@col-care.com
Source:Columbia Care Inc.